Bank of New York Mellon »

Denali Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $37M 1.8M 20.52
2023-12-31 $40M 1.9M 21.46
2023-09-30 $41M 2.0M 20.63
2023-06-30 $59M 2.0M 29.51
2023-03-31 $47M 2.0M 23.04
2022-12-31 $56M 2.0M 27.81
2022-09-30 $57M 1.9M 30.14
2022-06-30 $55M 1.9M 29.43
2022-03-31 $52M 1.6M 32.17
2021-12-31 $0 933k 0.00
2021-09-30 $19M 377k 50.47
2021-06-30 $27M 347k 78.44
2021-03-31 $15M 261k 57.10
2020-12-31 $37M 439k 83.76
2020-09-30 $26M 728k 35.83
2020-06-30 $16M 646k 24.18
2020-03-31 $6.0M 344k 17.51
2019-12-31 $5.9M 336k 17.42
2019-09-30 $5.2M 339k 15.32
2019-06-30 $4.7M 227k 20.76
2019-03-31 $5.3M 228k 23.22
2018-12-31 $4.7M 228k 20.66
2018-09-30 $4.4M 204k 21.74
2018-06-30 $934k 61k 15.26
2018-03-31 $1.0M 52k 19.69